英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
riehan查看　riehan　在百度字典中的解释百度英翻中〔查看〕
riehan查看　riehan　在Google字典中的解释Google英翻中〔查看〕
riehan查看　riehan　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Aducanumab - Wikipedia
    Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease [1][2] It is a monoclonal antibody [2][1] that targets aggregated forms (plaque) [3][4] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup [5][6] It was developed by Biogen and Eisai [7]
  • Role of Aducanumab in the Treatment of Alzheimer’s Disease: Challenges . . .
    Aducanumab is a monoclonal antibody selective for amyloid β (Aβ) aggregates In June 2021, aducanumab became the first drug underlying the pathophysiology of Alzheimer’s disease (AD) approved by the US Food and Drug Administration (FDA), under the accelerated approval pathway
  • Aducanumab Uses, Side Effects Warnings - Drugs. com
    What is aducanumab? Aducanumab is used to treat adults with Alzheimer's disease Aducanumab may also be used for purposes not listed in this medication guide
  • Aducanumab-avwa (intravenous route) - Side effects uses
    Description Aducanumab-avwa injection is used to treat Alzheimer's disease This medicine is to be given only by or under the supervision of your doctor
  • Aducanumab (marketed as Aduhelm) Information | FDA
    Aducanumab (marketed as Aduhelm) Information Aduhelm is an amyloid beta-directed antibody indicated to treat Alzheimer’s disease
  • Aducanumab: Frequently Asked Questions | Cleveland Clinic
    The FDA has approved the medicine aducanumab, for the treatment of Alzheimer’s disease This is the first new Alzheimer’s drug approved in 18 years and the first therapy that can slow progression of Alzheimer’s disease, not just treat its symptoms
  • Whats Next for Patients Treated With Aducanumab?
    As aducanumab, the first disease-modifying treatment for patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease (AD), sails into the sunset, neurologists are scrambling to figure out next steps for their patients treated with the drug





中文字典-英文字典  2005-2009